Shouyao Holdings (Beijing) Co., LTD. (SHA:688197)

China · Delayed Price · Currency is CNY

39.46

+0.38 (0.97%)

At close: Sep 23, 2026

Market Cap	5.87B -14.0%
Revenue (ttm)	34.67M +1,518.4%
Net Income	-85.52M
EPS	-0.58
Shares Out	148.72M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,401,316
Open	38.89
Previous Close	39.08
Day's Range	38.40 - 40.20
52-Week Range	29.71 - 48.97
Beta	0.67
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 29, 2026

About SHA:688197

Shouyao Holdings (Beijing) Co., LTD. engages in the research, development, and production of drugs in China. The company offers drugs for oncology indications, including non-small cell lung cancer, lymphoma, hepatocellular carcinoma, pancreatic cancer, breast cancer, ovarian cancer, thyroid cancer, leukemia, and diabetes. The company was founded in 2016 and is headquartered in Beijing, China. [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2016

Employees 184

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 688197

Full Company Profile

Financial Performance

In 2025, SHA:688197's revenue was 8.67 million, an increase of 119.88% compared to the previous year's 3.94 million. Losses were -128.83 million, -39.21% less than in 2024.

Financial Statements